Study finds unmedicated women with depression have lower heat tolerance than those on SSRIs

Selective serotonin reuptake inhibitors (SSRIs), the most widely prescribed class of antidepressants, have recently been linked in media reports and social‑media discussions to an increased susceptibility to heat‑related illnesses. The Centers for Disease Control and Prevention (CDC) has acknowledged the growing concern, noting that SSRIs can alter thermoregulatory processes and may impair the body’s ability to dissipate heat, thereby raising the risk of heat exhaustion or heat stroke in hot weather.

The CDC’s statement cites preliminary research suggesting that SSRIs may blunt sweating and reduce cardiovascular responses to heat exposure. While the agency stresses that definitive large‑scale studies are still pending, it recommends that patients on SSRIs take extra precautions during heat waves, such as staying hydrated, avoiding strenuous activity during peak temperatures, and monitoring for early signs of overheating. Health professionals are advised to discuss heat‑risk mitigation with patients who are prescribed these medications, especially in regions prone to extreme temperatures.

In summary, the emerging evidence and public health guidance underscore the need for heightened vigilance among SSRI users during periods of elevated heat. By adopting preventive measures and staying informed about the latest CDC recommendations, individuals on these medications can reduce their likelihood of heat‑related complications.